Antigen-Specific Cytotoxic T Cells Mediate Human Fetal Pancreas Allograft Rejection in SCID-hu Mice

Journal of Immunology

Volumn 157, Issue 12, 1996, Pages 5710-5720

  Rouleau, Matthieu ^a   Namikawa, Reiko ^a   Antonenko, Svetlana ^a   Carballido Perrig, Nicole ^a   Roncarolo, Maria Grazia ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DISEASE MODEL; FETUS; GENETICS; GRAFT REJECTION; HUMAN; IMMUNOLOGY; MOUSE; MOUSE MUTANT; PANCREAS TRANSPLANTATION; PATHOLOGY; THYMUS; XENOGRAFT;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; FETUS; GRAFT REJECTION; HLA ANTIGENS; HUMANS; MICE; MICE, SCID; PANCREAS TRANSPLANTATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, CYTOTOXIC; THYMUS GLAND; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030589303     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Suthanthiran, M., and T. B. Strom. 1994. Renal transplantation. N. Engl. J. Med. 331:365.
2. Hayry, P., H. Isoniemi, S. Yilmaz, A. Mennander, K. Lemstrom, A. Raisanen-Sokolowski, P. Koskinen, J. Ustinov, I. Lautenschlager, E. Taskinen, L. Krogerus, P. Aho, and T. Paavonen. 1993. Chronic allograft rejection. Immunol. Rev. 134:33.
3. Fathman, C. G. 1992. Inhibition of immune induction: the target of current transplantation tolerance strategies. Curr. Opin. Immunol. 4:545.
4. Charlton, B., H. Auchincloss, Jr., and C. G. Fathman. 1994. Mechanisms of transplantation tolerance. Annu. Rev. Immunol. 12:707.
5. Wecker, H., and H. Auchincloss, Jr. 1992. Cellular mechanisms of rejection. Curr. Opin. Immunol. 4:561.
6. Adams, D. H., M. E. Russell, W. W. Hancock, M. H. Sayegh, L. R. Wyner, and M. J. Karnovsky. 1993. Chronic rejection in experimental cardiac transplantation: studies in the Lewis-F344 model. Immunol. Rev. 134:5.
7. Tufveson, G., G. Gannedahl, C. Johnsson, M. Olausson, A. Wanders, and H. Ekberg. 1993. New immunosuppressants: testing and development in animal models and the clinic: with special reference to DSG. Immunol. Rev. 136:99.
8. Bosma, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301:527.
9. Schuler, W., I. J. Weiler, A. Schuler, R. A. Phillips, N. Rosenberg, T. W. Mak, J. F. Kearney, R. P. Perry, and M. J. Bosma. 1986. Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell 46:963.
10. Bosma, M. J., and A. M. Carroll. 1991. The SCID mouse mutant: definition, characterization, and potential uses. Annu. Rev. Immunol. 9:323.
11. Mosier, D. E., R. J. Gulizia, S. M. Baird, and D. B. Wilson. 1988. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256.
12. McCune, J. M., R. Namikawa, H. Kaneshima, L. D. Shultz, M. Lieberman, and I. L. Weissman. 1988. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632.
13. Namikawa, R., K. N. Weilbaecher, H. Kaneshima, E. J. Yee, and J. M. McCune. 1990. Long-term human hematopoiesis in the SCID-hu mouse. J. Exp. Med. 172:1055.
14. Vandekerckhove, B. A., R. Baccala, D. Jones, D. H. Kono, A. N. Theotilopoulos, and M. G. Roncarolo. 1992. Thymic selection of the human T cell receptor V beta repertoire in SCID-hu mice. J. Exp. Med. 176:1619.
15. high human thymocytes are activated and already functionally differentiated in helper and cytotoxic cells. J. Immunol. 152:1738.
16. Krowka, J. F., S. Sarin, R. Namikawa, J. M. McCune, and H. Kaneshima. 1991. Human T cells in the SCID-hu mouse are phenotypically normal and functionally competent. J. Immunol. 146:3751.
17. Vandekerckhove, B. A., J. F. Krowka, J. M. McCune, J. E. de Vries, H. Spits, and M. G. Roncarolo. 1991. Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse. J. Immunol 146:4173.
18. Tuch, B. E., and R. S. Monk. 1991. Regulation of blood glucose to human levels by human fetal pancreatic xenografts. Transplantation 51:1156.
19. Tuch, B. E., R. S. Monk, and J. Beretov. 1991. Reversal of diabetes in athymic rats by transplantation of human fetal pancreas. Transplantation 52:172.
20. Goldrath, A. W., K. E. Chen, L. G. Weide, P. M. Pour, J. S. Lebkowski, and S. E. Alters. 1995. Retention of endocrine function in the SCID-Hu pancreas mouse-a model for the development of human fetal islet tissue. Transplantation 59:1497.
21. Tuch, B. E. 1992. Clinical results of transplanting fetal pancreas. In Fetal Tissue Transplants in Medicine. R. G. Edwards, ed. Cambridge University Press, Cambridge, p. 215.
22. Lafferty, K. J., S. J. Prowse, C. J. Simeonovic, and H. S. Warren. 1983. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu. Rev. Immunol. 1:143.
23. Kyoizumi, S., C. M. Baum, H. Kaneshima, J. M. McCune, E. J. Yee, and R. Namikawa. 1992. Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood 79:1704.
24. Carballido, J. M., D. Schols, R. Namikawa, S. Zurawski, G. Zurawski, M.-G. Roncarolo, and J. E. de Vries. 1995. IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice: Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist. J. Immunol. 155:4162.
25. Hogan, K. T., C. Clayberger, E. J. Bernhard, S. F. Walk, J. P. Ridge, P. Parham, A. M. Krensky, and V. H. Engelhard. 1989. A panel of unique HLA-A2 mutant molecules define epilopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes. J. Immunol. 142:2097.
26. Spits, H., G. Keizer, J. Borst, C. Terhorst, A. Hekman, and J. E. de Vries. 1983. Characterization of monoclonal antibodies against cell surface molecules associated with cytotoxic activity of natural and activated killer cells and cloned CTL lines. Hybridoma 2:423.
27. Malissen, B., N. Rebai, A. Liabeuf, and C. Mawas. 1982. Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis-inhibiting effect of 7 monoclonal antibodies. Eur. J. Immunol. 12:739.
28. Pujol-Borrell, R., I. Todd, M. Doshi, G. F. Bottazzo, R. Sutton, D. Gray, G. R. Adolf, and M. Feldmann. 1987. HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature 326:304.
29. Mason, D. W., and P. J. Morris. 1986. Effector mechanisms in allograft rejection. Annu. Rev. Immunol. 4:119.
30. + T cell in allograft rejection. J. Immunol. 139:4022.
31. Gill, R. G., A. S. Rosenberg, K. J. Lafferty, and A. Singer. 1989. Characterization of primary T cell subsets mediating rejection of pancreatic islet grafts. J. Immunol. 143:2176.
32. Bishop, D. K., S. Chan, W. Li, R. D. Ensley, S. Xu, and E. J. Eichwald. 1993. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes. Transplantation 56:892.
33. Gill, R. G. 1993. T-cell-T-cell collaboration in allograft responses. Curr. Opin. Immunol. 5:782.
34. - T cells in beta 2-microglobulin, major histocompatibility complex class I-deficient mice. Eur. J. Immunol. 23:3115.
35. Zijlstra, M., H. J. Auchincloss, I. M. Loring, C. M. Chase, P. S. Russell, and R. Jaenisch. 1992. Skin graft rejection by beta 2-microglobulin-deficient mice. J. Exp. Med. 175:885.
36. +. Proc. Natl. Acad Sci. USA 79:2365.
37. + effector T-cells recognized products of different major histocompatibility complex regions. Proc. Natl. Acad. Sci. USA 79:4395.
38. + cytotoxic T-lymphocyte clones directed at products of different class II major histocompatibility complex loci. J. Immunol. 131:678.
39. Datema, G., L. B. M. Vaessen, R. C. Daane, C. C. Baan, W. Weimar, F. H. J. Claas, and P. J. van den Elsen. 1994. Functional and molecular characterization of graft-infiltrating T lymphocytes propagated from different biopsies derived from one heart transplant patient. Transplantation 57:1119.
40. Tuch, B. E., A. G. Sheil, A. B. Ng, R. J. Trent, and J. R. Turtle. 1988. Recovery of human fetal pancreas after one year of implantation in the diabetic patient. Transplantation 46:865.
41. Lafferty, K. J., L. Hao, S. K. Babcock, and E. Specs. 1989. Is there a future for fetal pancreas transplantation? Transplant. Proc. 21:2611.
42. Federlin, K. F., R. G. Bretzel, and B. J. Hering. 1992. Islet transplant registry. In Pancreatic Islet Cell Transplantation. C. Ricordi, ed. R. G. Landes Company, Austin, p. 462.
43. Faustman, D., and C. Coe. 1991. Prevention of xenograft rejection by masking donor HLA class I antigens. Science 252:1700.
44. Falqui, L., E. H. Finke, J. C. Carel, D. W. Scharp, and P. E. Lacy. 1991. Marked prolongation of human islet xenograft survival (human-to-mouse) by low-temperature culture and temporary immunosuppression with human and mouse antilymphocyte sera. Transplantation 51:1322.
45. Kawamura, T., T. Niguma, J. H. Fechner, Jr., R. Wolber, M. A. Beeskau, D. A. Hullett, H. W. Sollinger, and W. J. Burlingham. 1992. Chronic human skin graft rejection in severe combined immunodeficient mice engrafted with human PBL from an HLA-presensitized donor. Transplantation 53:659.
46. Murray, A G., P. Petzelbauer, C. C. Hughes, J. Costa, P. Askenase, and J. S. Pober. 1994. Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse. Proc. Natl. Acad. Sci. USA 91:9146.
47. Shiroki, R., N. J. Poindexter, T. Mohanakumar, and D. W. Scharp. 1994. Rejection of human islet allografts in human lymphocyte-reconstituted severe combined immunodeficient mice. Transplant. Proc. 26:716.
48. Alegre, M. L., L. J. Peterson, D. R. Jeyarajah, M. Weiser, J. A. Bluestone, and J. R. Thistlethwaite. 1994. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts. J. Immunol. 153:2738.
49. Tary-Lehmann, M., and A. Saxon. 1992. Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J. Exp. Med. 175:503.
50. + T cell repertoire in hu-PBL-SCID chimeras. J. Exp. Med. 180:1817.